Literature DB >> 23109112

The association between neonatal thyroxine and craniosynostosis, Texas, 2004-2007.

Syed Shahrukh Hashmi1, Mark A Canfield, Lisa Marengo, Karen B Moffitt, John W Belmont, Debra Freedenberg, Susan M Tanksley, Philip J Lupo.   

Abstract

BACKGROUND: Craniosynostosis (CS), a structural anomaly characterized by premature fusion of cranial sutures, occurs in 1 in 2000 live births. Associations of CS with the thyroid have been reported. Neonatal thyroid hormone (T4) is evaluated nationally at birth by the Newborn Screening Program (NBS). This study evaluated the relationship between NBS T4 levels and craniosynostosis.
METHODS: Live-born singleton babies born in 2004 through 2007 were identified through the Texas Birth Defects Registry (499 cases) and Texas Bureau of Vital Statistics (3570 controls) and successfully linked to analyte data available in the Texas NBS Database. Cases were classified based on the absence of other major defects (isolated cases, n = 382) and suture(s) involved. Mean T4 levels were compared between controls and cases (overall and stratified by classification). T4 levels were stratified by quintiles to evaluate differences between cases and controls within quintiles. The diagnostic utility of NBS T4 was evaluated using receiver operator characteristic (ROC) curves.
RESULTS: Mean T4 levels were lower in isolated cases (16.89 μg/dl) than in controls (17.77 μg/dl; p = 0.0004). This trend persisted for sagittal (16.69 μg/dl; p = 0.002) and metopic (16.83 μg/dl; p = 0.042) CS. When stratified by quintiles, 54% of isolated lambdoid CS were in the first quintile compared to controls (p = 0.012). ROC area under the curve (AUC) was approximately 0.55 for all classifications except lambdoid (AUC = 0.73).
CONCLUSION: NBS T4 levels were slightly lower among cases with nearly half of all lambdoid CS having T4 levels in the lowest quintile. However, overall NBS T4 levels are not suitable for potential screening or diagnostic application.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23109112     DOI: 10.1002/bdra.23077

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  4 in total

1.  Effects of thyroxine exposure on the Twist 1 +/- phenotype: A test of gene-environment interaction modeling for craniosynostosis.

Authors:  Emily L Durham; R Nicole Howie; Laurel Black; Grace Bennfors; Trish E Parsons; Mohammed Elsalanty; Jack C Yu; Seth M Weinberg; James J Cray
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-07-20

2.  Craniosynostosis and risk factors related to thyroid dysfunction.

Authors:  S L Carmichael; C Ma; S A Rasmussen; M L Cunningham; M L Browne; C Dosiou; E J Lammer; G M Shaw
Journal:  Am J Med Genet A       Date:  2015-02-05       Impact factor: 2.802

3.  Effects of thyroxine exposure on osteogenesis in mouse calvarial pre-osteoblasts.

Authors:  James J Cray; Kameron Khaksarfard; Seth M Weinberg; Mohammed Elsalanty; Jack C Yu
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

4.  Effects of In Utero Thyroxine Exposure on Murine Cranial Suture Growth.

Authors:  R Nicole Howie; Emily L Durham; Laurel Black; Grace Bennfors; Trish E Parsons; Mohammed E Elsalanty; Jack C Yu; Seth M Weinberg; James J Cray
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.